CRISPR Therapeutics AG

US BANCORP \DE\ CRSP

Report date

12/31/2025

Quarter

2025 Q4

Filed

1/30/2026

Shares

5,731

Value ($000)

301

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	1/30/2026	301	0.0%	5,731	12/31/2025
2025 Q3	11/12/2025	374	0.0%	5,777	9/30/2025
2025 Q2	7/24/2025	269	0.0%	5,528	6/30/2025
2025 Q1	5/8/2025	104	0.0%	3,063	3/31/2025
2024 Q4	2/5/2025	48	0.0%	1,209	12/31/2024
2024 Q3	10/28/2024	122	0.0%	2,589	9/30/2024
2024 Q2	8/7/2024	314	0.0%	5,817	6/30/2024
2024 Q1	5/8/2024	398	0.0%	5,841	3/31/2024
2023 Q4	2/9/2024	366	0.0%	5,849	12/31/2023
2023 Q3	11/3/2023	288	0.0%	6,343	9/30/2023
2023 Q2	8/10/2023	381	0.0%	6,795	6/30/2023
2023 Q1	5/9/2023	341	0.0%	7,550	3/31/2023
2022 Q4	2/13/2023	280	0.0%	6,891	12/31/2022
2022 Q3	10/27/2022	870	0.0%	13,316	9/30/2022
2022 Q2	8/1/2022	533	0.0%	8,767	6/30/2022
2022 Q1	5/11/2022	598	0.0%	9,526	3/31/2022
2021 Q4	2/11/2022	657	0.0%	8,660	12/31/2021
2021 Q3	11/10/2021	805	0.0%	7,196	9/30/2021
2021 Q2	8/5/2021	944	0.0%	5,829	6/30/2021
2021 Q1	4/28/2021	638	0.0%	5,230	3/31/2021
2020 Q4	2/4/2021	193	0.0%	1,257	12/31/2020
2020 Q3	11/10/2020	100	0.0%	1,195	9/30/2020
2020 Q2	8/7/2020	169	0.0%	2,295	6/30/2020
2020 Q1	5/13/2020	97	0.0%	2,295	3/31/2020
2019 Q4	2/4/2020	132	0.0%	2,170	12/31/2019